While Honda Sales Boomed In The U.S., Europe Was Allowed To Stagnate

France Nouvelles Nouvelles

While Honda Sales Boomed In The U.S., Europe Was Allowed To Stagnate
France Dernières Nouvelles,France Actualités
  • 📰 Forbes
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 53%

Honda’s decision to shut its British factory was more a result of its lack of ambition in Europe rather than a need to restructure

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

Forbes /  🏆 394. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

30 Under 30 Europe 2019: Art & Culture30 Under 30 Europe 2019: Art & CultureHow Conna Walker carved out her own path with House of CB: ForbesUnder30
Lire la suite »

The UK is the only country in Europe losing inbound tourismThe UK is the only country in Europe losing inbound tourismEven though demand for European destinations increased by six percent in 2018, the UK saw its inbound tourism taking a dive with a 5.3 percent decrease compared to 2017.
Lire la suite »

Should Europe uphold the right to return — even for Daesh families?Should Europe uphold the right to return — even for Daesh families?European powers are yet to claim their citizens, who want to return home from former Daesh-held territories in Syria, posing a significant question over whether the legal principle of the right to return will be applied.
Lire la suite »

Europe Again Champions Intervention to Counter China’s Economic MightEurope Again Champions Intervention to Counter China’s Economic MightEurope’s struggle to keep up with China’s government coordination of business and economic might of the U.S. has prompted more European politicians to advocate interventionism.
Lire la suite »

World’s best-selling drug costs five times more in U.S. than EuropeWorld’s best-selling drug costs five times more in U.S. than EuropeCritics accuse the maker of Humira of exploiting U.S. patent laws to keep competitors’ less expensive versions off the market. The company, AbbVie, says it’s balancing the need to keep the drug affordable to patients with the need to fund new drug development.
Lire la suite »



Render Time: 2025-03-13 04:37:16